Patent 7550463 was granted and assigned to Shionogi on June, 2009 by the United States Patent and Trademark Office.
An object of the present invention provides a novel compound having the anti-viral activity, particularly, the HIV integrase inhibitory activity, and a drug containing the same, particularly, an anti-HIV drug.